Detalles de la búsqueda
1.
Transitions of blood immune endotypes and improved outcome by anakinra in COVID-19 pneumonia: an analysis of the SAVE-MORE randomized controlled trial.
Crit Care
; 28(1): 73, 2024 03 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38475786
2.
Mortality in KPC-producing Klebsiella pneumoniae bloodstream infections: a changing landscape.
J Antimicrob Chemother
; 78(10): 2505-2514, 2023 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37606528
3.
Efficacy and safety of early soluble urokinase plasminogen receptor plasma-guided anakinra treatment of COVID-19 pneumonia: A subgroup analysis of the SAVE-MORE randomised trial.
EClinicalMedicine
; 56: 101785, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36590789
4.
Pre- and in-hospital anticoagulation therapy in coronavirus disease 2019 patients: a propensity-matched analysis of in-hospital outcomes.
J Cardiovasc Med (Hagerstown)
; 23(4): 264-271, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34878430
5.
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial.
Nat Med
; 27(10): 1752-1760, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34480127
6.
Differential diagnosis of lung nodules: breast cancer metastases and lung tuberculosis.
Infez Med
; 18(1): 39-42, 2010 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-20424525
7.
Author Correction: Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial.
Nat Med
; 27(10): 1850, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34625750
Resultados
1 -
7
de 7
1
Próxima >
>>